Department of Cardiology, The First Affiliated Hospital, University of China Medical, China Medical University, 155th North of Nanjing Street, Heping District, Shenyang 110001, Liaoning Province, China.
Cell Biochem Biophys. 2011 Jul;60(3):219-24. doi: 10.1007/s12013-010-9142-8.
To study the protective effect of mitochondrial ATP-sensitive K(+) channel (mitoK(ATP) channel) opener, nicorandil, combined with Na(+)/Ca(2+) exchange blocker KB-R7943 on myocardial ischemia-reperfusion injury in isolated rat hearts; the isolated rat heart was perfused by modified Langendorff device, after 15-min balanced perfusion, 45-min ischemia (about left and right coronary perfusion flow reduced to 5% of the original irrigation flow), and 2-h reperfusion were performed. Forty Wistar rats were randomly divided into four groups: control group, nicorandil group, KB-R7943 group, and the combination of nicorandil and KB-R7943 group. After 45-min ischemia and then 2-h reperfusion, the myocardial infarct size was 34.31% in control group, 26.35% in nicorandil group, 28.74% in KB-R7943 group, and 19.23% in combination of nicorandil and KB-R7943 group. SOD activity in coronary perfusion fluid was the highest in the combination of nicorandil and KB-R7943 group, and MDA content was the lowest. In the combination drug group compared with the control group, myocardial ultrastructural injury was significantly reduced. The combination of nicorandil and KB-R7943 significantly reduced myocardial infarct size, significantly reduced myocardial ultrastructural damage, could increase coronary perfusion fluid SOD activity, and reduced MDA levels.
为了研究线粒体三磷酸腺苷敏感钾(mitoKATP)通道(mitoKATP 通道)开放剂尼可地尔与 Na(+)/Ca(2+)交换抑制剂 KB-R7943 联合对缺血再灌注损伤心肌的保护作用,采用改良 Langendorff 装置灌流大鼠心脏,平衡灌流 15min 后,进行 45min 缺血(约左、右冠状动脉灌流流量减少至原灌流流量的 5%)和 2h 再灌注。40 只 Wistar 大鼠随机分为四组:对照组、尼可地尔组、KB-R7943 组、尼可地尔和 KB-R7943 联合组。缺血 45min 后再灌注 2h,对照组心肌梗死面积为 34.31%,尼可地尔组为 26.35%,KB-R7943 组为 28.74%,尼可地尔和 KB-R7943 联合组为 19.23%。尼可地尔和 KB-R7943 联合组冠状动脉灌流液中超氧化物歧化酶(SOD)活性最高,丙二醛(MDA)含量最低。与对照组相比,联合用药组心肌超微结构损伤明显减轻。尼可地尔和 KB-R7943 联合用药显著降低心肌梗死面积,显著减轻心肌超微结构损伤,增加冠状动脉灌流液 SOD 活性,降低 MDA 水平。